Trial · NCT03172702
Results by group138
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 138
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Patients Who Experienced Adverse Events (AEs) in the MP | Sodium Zirconium Cyclosilicate | Any AE | 131 | Participants | |
| Number of Patients Who Experienced Adverse Events (AEs) in the MP | Sodium Zirconium Cyclosilicate | Any AE with outcome death | 2 | Participants | |
| Number of Patients Who Experienced Adverse Events (AEs) in the MP | Sodium Zirconium Cyclosilicate | Any SAE | 27 | Participants | |
| Number of Patients Who Experienced Adverse Events (AEs) in the MP | Sodium Zirconium Cyclosilicate | Any severe AE | 9 | Participants | |
| Number of Patients Who Experienced Adverse Events (AEs) in the MP | Sodium Zirconium Cyclosilicate | Any AE leading to ZS discontinuation | 12 | Participants | |
| Number of Patients Who Experienced Adverse Events (AEs) in the MP | Sodium Zirconium Cyclosilicate | Any causally related AE | 30 | Participants | |
| Number of Patients Who Experienced Adverse Events (AEs) in the MP | Sodium Zirconium Cyclosilicate | Oedema-related AE | 31 | Participants | |
| Number of Patients Who Experienced Adverse Events (AEs) in the MP | Sodium Zirconium Cyclosilicate | Cardiac failure | 10 | Participants | |
| Number of Patients Who Experienced Adverse Events (AEs) in the MP | Sodium Zirconium Cyclosilicate | Hypertension | 24 | Participants | |
| Percentage of Patients Who Were Normokalemic in the MP | Sodium Zirconium Cyclosilicate | MP Day 1 | 82.0 | 95% Confidence Interval 74.9 to 87.8 | Percentage of patients |
| Percentage of Patients Who Were Normokalemic in the MP | Sodium Zirconium Cyclosilicate | MP Day 2 | 78.7 | 95% Confidence Interval 71.2 to 84.9 | Percentage of patients |
| Percentage of Patients Who Were Normokalemic in the MP | Sodium Zirconium Cyclosilicate | MP Day 5 | 79.9 | 95% Confidence Interval 72.5 to 86.0 | Percentage of patients |
| Percentage of Patients Who Were Normokalemic in the MP | Sodium Zirconium Cyclosilicate | MP Day 12 | 67.8 | 95% Confidence Interval 59.6 to 75.2 | Percentage of patients |
| Percentage of Patients Who Were Normokalemic in the MP | Sodium Zirconium Cyclosilicate | MP Day 19 | 65.5 | 95% Confidence Interval 57.3 to 73.2 | Percentage of patients |
| Percentage of Patients Who Were Normokalemic in the MP | Sodium Zirconium Cyclosilicate | MP Day 26 | 72.3 | 95% Confidence Interval 64.3 to 79.3 | Percentage of patients |
| Percentage of Patients Who Were Normokalemic in the MP | Sodium Zirconium Cyclosilicate | MP Day 54 | 76.4 | 95% Confidence Interval 68.6 to 83.1 | Percentage of patients |
| Percentage of Patients Who Were Normokalemic in the MP | Sodium Zirconium Cyclosilicate | MP Day 82 | 72.1 | 95% Confidence Interval 63.9 to 79.4 | Percentage of patients |
| Percentage of Patients Who Were Normokalemic in the MP | Sodium Zirconium Cyclosilicate | MP Day 110 | 75.9 | 95% Confidence Interval 67.9 to 82.8 | Percentage of patients |
| Percentage of Patients Who Were Normokalemic in the MP | Sodium Zirconium Cyclosilicate | MP Day 138 | 85.1 | 95% Confidence Interval 77.9 to 90.6 | Percentage of patients |
| Percentage of Patients Who Were Normokalemic in the MP | Sodium Zirconium Cyclosilicate | MP Day 166 | 78.0 | 95% Confidence Interval 70.0 to 84.8 | Percentage of patients |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03172702/results